NM_001323289.2:c.2445C>T
Variant summary
Our verdict is Benign. The variant received -9 ACMG points: 0P and 9B. BP7BA1
This summary comes from the ClinGen Evidence Repository: The allele frequency of the p.Ser815= variant in CDKL5 is 0.1% in African sub population in gnomAD, which is high enough to be classified as benign based on thresholds defined by the ClinGen Rett/Angelman-like Expert Panel for Rett/AS-like conditions (BA1). The silent p.Ser815= variant is not predicted to affect splicing using multiple computational tools and does not affect a highly conserved nucleotide (BP7). In summary, the p.Ser815= variant in CDKL5 is classified as benign based on the ACMG/AMP criteria (BA1, BP7). LINK:https://erepo.genome.network/evrepo/ui/classification/CA10360539/MONDO:0100039/016
Frequency
Consequence
NM_001323289.2 synonymous
Scores
Clinical Significance
Conservation
Publications
- CDKL5 disorderInheritance: XL Classification: DEFINITIVE Submitted by: ClinGen
- developmental and epileptic encephalopathy, 2Inheritance: XL Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Orphanet, G2P, Labcorp Genetics (formerly Invitae), Ambry Genetics
- atypical Rett syndromeInheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
- genetic developmental and epileptic encephalopathyInheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
- infantile spasmsInheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
- precocious pubertyInheritance: XL Classification: LIMITED Submitted by: Ambry Genetics
Genome browser will be placed here
ACMG classification
Our verdict: Benign. The variant received -9 ACMG points.
Transcripts
RefSeq
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|
| CDKL5 | NM_001323289.2 | c.2445C>T | p.Ser815Ser | synonymous_variant | Exon 17 of 18 | ENST00000623535.2 | NP_001310218.1 | |
| CDKL5 | NM_001037343.2 | c.2445C>T | p.Ser815Ser | synonymous_variant | Exon 18 of 22 | NP_001032420.1 | ||
| CDKL5 | NM_003159.3 | c.2445C>T | p.Ser815Ser | synonymous_variant | Exon 17 of 21 | NP_003150.1 |
Ensembl
Frequencies
GnomAD3 genomes AF: 0.000209 AC: 23AN: 109884Hom.: 0 Cov.: 22 show subpopulations
GnomAD2 exomes AF: 0.0000875 AC: 16AN: 182778 AF XY: 0.0000595 show subpopulations
GnomAD4 exome AF: 0.0000256 AC: 28AN: 1094288Hom.: 0 Cov.: 30 AF XY: 0.0000222 AC XY: 8AN XY: 359898 show subpopulations
Age Distribution
GnomAD4 genome AF: 0.000209 AC: 23AN: 109938Hom.: 0 Cov.: 22 AF XY: 0.000187 AC XY: 6AN XY: 32170 show subpopulations
Age Distribution
ClinVar
Submissions by phenotype
not specified Benign:1
- -
CDKL5 disorder Benign:1
The allele frequency of the p.Ser815= variant in CDKL5 is 0.1% in African sub population in gnomAD, which is high enough to be classified as benign based on thresholds defined by the ClinGen Rett/Angelman-like Expert Panel for Rett/AS-like conditions (BA1). The silent p.Ser815= variant is not predicted to affect splicing using multiple computational tools and does not affect a highly conserved nucleotide (BP7). In summary, the p.Ser815= variant in CDKL5 is classified as benign based on the ACMG/AMP criteria (BA1, BP7). -
not provided Benign:1
- -
Developmental and epileptic encephalopathy, 2;CN128785:Angelman syndrome-like Benign:1
- -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at